Androgenetic Alopecia

Search with Google Search with Bing
Information
Disease name
Androgenetic Alopecia
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06066827 Active, not recruiting N/A Hair Regeneration in Androgenetic Alopecia August 14, 2023 November 30, 2023
NCT06043349 Active, not recruiting Phase 4 Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia June 1, 2023 September 30, 2023
NCT06126965 Active, not recruiting Phase 3 Phase III Study of KX-826 With Adult Male Patients With AGA December 29, 2021 May 31, 2024
NCT05456087 Active, not recruiting Phase 2 Use of Botulinum Toxin in the Treatment of Androgenic Alopecia August 12, 2022 December 2024
NCT00947219 Completed N/A Treatment of Androgenic Alopecia in Males July 2009 August 2010
NCT00947505 Completed N/A Treatment of Androgenetic Alopecia in Males August 2009 August 2010
NCT00958750 Completed Phase 3 Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia June 2008 June 2009
NCT00981461 Completed N/A Treatment of Androgenetic Alopecia in Females, 9 Beam October 2009 October 2010
NCT01016964 Completed N/A Treatment of Androgenetic Alopecia in Females, 12 Beam January 2010 March 2011
NCT01052870 Completed Phase 1 Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia December 2008 December 2009
NCT01226459 Completed Phase 3 Clinical Trial in Females for Female Pattern Hair Loss September 2010 August 2011
NCT01231607 Completed Phase 3 Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia October 28, 2010 February 28, 2012
NCT01286649 Completed Phase 1/Phase 2 Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia December 2010 February 23, 2017
NCT01309191 Completed N/A Microarray Analysis of Scalp Biopsies After Minoxidil Treatment April 2011 April 2012
NCT01319370 Completed Phase 2 Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia November 2010 March 2013
NCT01391156 Completed Phase 3 Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss March 2011 March 2012
NCT01437163 Completed N/A Treatment of Androgenetic Alopecia in Males and Females September 2011 August 2013
NCT01451021 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss October 2008
NCT01451047 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) July 2009
NCT01451073 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) January 2009
NCT01451099 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss June 2009
NCT01451112 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) August 2009
NCT01451125 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) May 2010
NCT01451138 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) November 2010
NCT01451151 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) December 2010
NCT01451177 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) May 2010
NCT00151515 Completed Phase 3 A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss October 2003 July 2004
NCT01548066 Completed Phase 2 The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss September 2011 June 2012
NCT01451190 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) July 2011
NCT00396175 Completed Phase 3 Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) March 1998
NCT00418730 Completed Phase 2 Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss January 2007 April 2008
NCT00926211 Completed N/A Computer-Assisted Versus Manual Hair Harvest Comparative Study June 2009 September 2010
NCT01669746 Completed Phase 2 A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) June 2012
NCT01701271 Completed N/A Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females February 2001 June 2001
NCT01967277 Completed N/A A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy March 2014 September 2014
NCT02067260 Completed N/A A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
NCT02150187 Completed Phase 2 Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss May 2014 May 2015
NCT02170662 Completed Phase 2 Topical Bimatoprost Effect on Androgen Dependent Hair Follicles November 2009 May 2011
NCT02198261 Completed Minoxidil Response Testing in Males With Androgenetic Alopecia July 2014 October 2018
NCT02275351 Completed Phase 2 A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) November 2014 November 2015
NCT02279823 Completed Phase 2 A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia October 2014 May 2016
NCT02280603 Completed Phase 1/Phase 2 Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application January 2014 December 2014
NCT02494297 Completed DUS on the Prescribing Indications for CPA/EE in 5 European Countries March 6, 2015 October 31, 2016
NCT02503137 Completed Phase 2 A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing August 2015 April 2016
NCT02591355 Completed N/A Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment September 6, 2017 November 18, 2019
NCT02626780 Completed N/A Adipose-derived SVF for Treatment of Alopecia July 20, 2016 January 22, 2017
NCT02729415 Completed N/A Point-of-Care Adipose-derived Cells for Hair Growth October 2016 January 31, 2019
NCT02791243 Completed Phase 1 Photosensitization Study in Androgenetic Alopecia May 9, 2016 June 27, 2016
NCT02848300 Completed Phase 1 Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia July 2016 October 2016
NCT03376581 Completed Early Phase 1 The Utility of Platelet Rich Plasma in Hair Loss November 28, 2017 February 20, 2019
NCT03394235 Completed N/A Optimizing Parameters for Long-pulsed Nd:YAG Laser for Reducing Hair Shaft Diameter February 2, 2018 January 16, 2019
NCT03495817 Completed Phase 2 A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution March 22, 2018 October 30, 2019
NCT03689452 Completed N/A The Effect of Platelet Rich Plasma on Non-scarring Alopecia October 1, 2018 June 3, 2019
NCT03694067 Completed Androgenetic Alopecia and the JAK-STAT Pathway October 15, 2018 December 1, 2019
NCT03742518 Completed Phase 2/Phase 3 A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia November 1, 2018 December 31, 2020
NCT03753113 Completed Phase 3 Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5% November 28, 2018 September 2, 2019
NCT04019795 Completed Phase 3 Modulated Light Therapy in Participants With Pattern Hair Loss January 5, 2017 May 25, 2019
NCT04214808 Completed Phase 1 To Evaluate the Pharmacokinetics and Safety of AD-208 January 3, 2020 May 4, 2020
NCT04379752 Completed N/A Cold Plasma to Treat Hair Loss July 1, 2020 September 15, 2021
NCT04446429 Completed N/A Anti-Androgen Treatment for COVID-19 October 21, 2020 January 21, 2021
NCT04450589 Completed N/A A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss April 11, 2018 October 23, 2018
NCT04450602 Completed N/A A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss April 3, 2018 October 23, 2018
NCT04481412 Completed Phase 2/Phase 3 Topical Cetirizine in Androgenetic Alopecia in Females July 25, 2020 November 30, 2021
NCT04502901 Completed Phase 1 the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending January 14, 2020 January 15, 2021
NCT04774874 Completed Phase 2 A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers June 24, 2020 January 29, 2021
NCT04825561 Completed Phase 3 A Study to Evaluate the Efficacy and Safety of AD-208 June 9, 2021 June 1, 2023
NCT04898166 Completed Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19). December 1, 2020 March 31, 2021
NCT04945226 Completed Phase 1/Phase 2 A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 September 21, 2021 February 8, 2022
NCT04984707 Completed Phase 1 Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration January 28, 2019 October 24, 2019
NCT05324293 Completed Phase 1 To Evaluate the Safety, Tolerability and Efficacy in Male and Female With AGA Treated With HMI-115 Over a 24-week Treatment Period May 11, 2022 September 11, 2023
NCT05428449 Completed Phase 1 Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 February 10, 2022 April 6, 2023
NCT05636904 Completed Phase 1/Phase 2 Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men December 5, 2022 March 28, 2024
NCT05989165 Completed Phase 3 Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men June 1, 2023 September 15, 2023
NCT06149221 Completed N/A Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss September 1, 2023 April 12, 2024
NCT05864885 Not yet recruiting Phase 1 Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia June 9, 2023 July 17, 2023
NCT05888922 Not yet recruiting Phase 3 Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia June 2024 September 2025
NCT06218394 Recruiting N/A Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia December 14, 2023 December 31, 2024
NCT05365360 Recruiting N/A Sham LaserCap vs. LaserCap SD vs. LaserCap HD+ June 1, 2022 May 2025
NCT06393452 Recruiting Phase 2 Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA June 5, 2024 February 2025
NCT06118866 Recruiting Phase 2 A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia September 11, 2023 December 2024
NCT05970809 Recruiting N/A Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss June 1, 2023 September 1, 2024
NCT06218498 Recruiting N/A Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia November 24, 2023 December 31, 2024
NCT04594018 Recruiting Phase 3 Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia February 2, 2023 September 2025
NCT05677438 Recruiting Phase 2 A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia December 20, 2022 April 30, 2024
NCT06239207 Recruiting Phase 2 Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia September 21, 2023 July 21, 2024
NCT05990400 Recruiting Phase 2/Phase 3 Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia May 1, 2023 December 30, 2023
NCT05460611 Recruiting N/A 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia December 7, 2023 December 2025
NCT02548689 Terminated PAI-1 Expression in Non-scarring Hair Loss July 2015 June 2021
NCT02154503 Unknown status Phase 1 Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia April 2014 March 2017
NCT04558242 Unknown status N/A Low Level Light Device as a Primary Therapy for Androgenetic Alopecia August 1, 2020 August 1, 2021
NCT02393040 Unknown status N/A Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia January 2014 November 2015
NCT05348343 Unknown status Phase 1/Phase 2 Activated PRP for Treatment of Androgenetic Alopecia May 17, 2022 March 31, 2023
NCT01686295 Unknown status N/A 24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness July 2012 May 2013
NCT04293822 Unknown status Phase 4 Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia June 2020 November 2021
NCT01643629 Unknown status Phase 1/Phase 2 A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia January 2012 November 2012
NCT04191005 Unknown status Efficacy of Platelet-Rich Plasma Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysis January 7, 2020 January 30, 2020
NCT04209803 Unknown status Phase 4 N-Acetyl-Cysteine for Treatment of AGA in Men December 1, 2018 October 2020
NCT01655602 Unknown status Phase 1 Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation July 2012 May 2013
NCT02074943 Unknown status N/A Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia April 2014 December 2015
NCT02528552 Unknown status Phase 2 Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO August 2015 December 2016
NCT01644422 Unknown status Phase 1/Phase 2 Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant January 2012 November 2012
NCT01501617 Unknown status Phase 1/Phase 2 Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia December 2011 December 2012
NCT04842383 Unknown status Early Phase 1 Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series April 5, 2021 October 4, 2021
NCT01227031 Unknown status Pharmacogenomic Study of Androgenetic Alopecia October 2010 July 2011
NCT01885676 Unknown status N/A Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
NCT02999737 Unknown status Phase 4 Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia November 2016 August 2017
NCT00471510 Unknown status Phase 2 Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss May 2007
NCT03388840 Unknown status Phase 4 Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction January 15, 2018 March 2021
NCT05129800 Unknown status Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study December 2021 February 2022
NCT02486848 Withdrawn N/A Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil June 2016 December 2016
NCT04882969 Withdrawn N/A Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia September 1, 2021 December 31, 2024
NCT04379583 Withdrawn HairDx Analytical Validation Study June 15, 2020 December 6, 2021
NCT03852992 Withdrawn Phase 2 Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia September 30, 2022 July 1, 2023
NCT04368897 Withdrawn In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity May 1, 2020 December 1, 2022
NCT05129254 Withdrawn N/A Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia July 1, 2022 December 31, 2025
NCT03048461 Withdrawn Phase 2 The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia June 2019 December 2020